ArticleCancer research communications2022

Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers.

Husain Yar Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.